January 30, 2024 12:22 PM EST
Pharma
Marketing

Mar­ket­ingRx roundup: Astel­las menopause drug led NFL TV spend­ing; A pod­cast's deep dive in­to Novo's his­to­ry

Beth Snyder Bulik

Senior Editor

Astel­las in­tro­duces menopause drug to NFL au­di­ence: Astel­las spent more mon­ey ad­ver­tis­ing its menopause drug Veozah than any oth­er new brand on reg­u­lar NFL …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ab­b­Vie fi­nal­ly en­ters obe­si­ty race with $350M up­front for Gubra’s amylin

Trump’s sci­ence crack­down hits rare dis­ease re­search: ‘We need to sit down with Elon Musk’

Lex­i­con plots Phase 3 tri­al for di­a­bet­ic pain drug de­spite mid-stage flop

At least sev­en drug­mak­ers say they will par­tic­i­pate in round two of IRA ne­go­ti­a­tions 

Trump blog: Judge blocks lay­offs in some agen­cies, but not HHS

sponsored

The per­fect storm: Why every­thing is in place for 2025 to be the year of GxP AI

A service from the Financial Times